Great find Macrobee - As I posted timeline for launch late next year in the meantime I expect ADO to be earning development fees - Cant see them going into formal clinical trials without naming Anteo
"Our activities this year are around assay optimization with the reagent and installing our initial manufacturing line for the cartridge here in Eindhoven. We hope by the end of this year to be able to start the formal clinical trials."
As I said in the other thread - BBI first sales and royalties later this year and IMO My guess would be formal naming of Anteo as a partner over the next few months
Once BBI are on the market and Philips are named I expect others to follow - That is my view
ADO Price at posting:
19.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)